Trevigen Inc.

Trevigen Receives a NIH SBIR Contract to Develop a Tumor Aligned 3D Coculture System

LogoTrevigen Inc. has been awarded $252,000 for the Small Business Innovation Research (SBIR) Phase I Contract, 261201300042C, from the National Cancer Institute and the National Institutes of Health (NIH) to develop a tumor-aligned 3D coculture system. Dr. Gabriel Benton is the Principal Investigator.